Enhanced posttransplant management of patients with diabetes improves patient outcomes

Mira Keddis, Mireille El Ters, Emilio Rodrigo, Patrick Dean, Mariana Wohlfahrtova, Yogish C Kudva, Elizabeth C. Lorenz, Fernando G Cosio

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The survival of patients with diabetes mellitus in the general population has improved in recent years. Here we assessed whether similar trends have occurred in 1688 kidney recipients, including 413 with diabetes prior to transplant between 1996 and 2007. Compared to patients without diabetes, the 5-year mortality was significantly increased (hazard ratio (HR) 2.68 (1.95-3.69)) due to higher cardiovascular-, infection-, and malignancy-related deaths in those with diabetes. However, 5-year mortality in patients with diabetes significantly declined over time (HR 0.883 (0.817-0.954)), narrowing the mortality difference between patients with and those without diabetes and in more recent years largely eliminating it. Post transplant, patients with diabetes experienced a significant decline in major fatal/nonfatal cardiac events (HR 0.853 (0.782-0.930)) and infectious deaths over time. In contrast, neither cardiac events nor overall mortality declined in recipients without diabetes. The decline in mortality due to diabetes did not relate to a reduced pretransplant risk profile and was independent of posttransplant variables. The use of cardioprotective medications and glycemic control improved over time post transplant. Furthermore, graft function and serum albumin significantly improved over time and these parameters related to better survival (albumin, HR 0.365 (0.223-0.599); eGFR, HR 0.803 (0.756-0.852)). Thus, survival of kidney recipients with diabetes mellitus has improved markedly since 1996 likely reflecting, at least in part, enhanced posttransplant management and outcomes.

Original languageEnglish (US)
Pages (from-to)610-618
Number of pages9
JournalKidney International
Volume86
Issue number3
DOIs
StatePublished - 2014

Fingerprint

Mortality
Transplants
Diabetes Mellitus
Cardiovascular Infections
Kidney
Survival
Serum Albumin
Albumins
Population
Neoplasms

Keywords

  • cardiovascular morbidity
  • cardiovascular mortality
  • diabetes mellitus
  • patient survival

ASJC Scopus subject areas

  • Nephrology

Cite this

Enhanced posttransplant management of patients with diabetes improves patient outcomes. / Keddis, Mira; El Ters, Mireille; Rodrigo, Emilio; Dean, Patrick; Wohlfahrtova, Mariana; Kudva, Yogish C; Lorenz, Elizabeth C.; Cosio, Fernando G.

In: Kidney International, Vol. 86, No. 3, 2014, p. 610-618.

Research output: Contribution to journalArticle

Keddis, Mira ; El Ters, Mireille ; Rodrigo, Emilio ; Dean, Patrick ; Wohlfahrtova, Mariana ; Kudva, Yogish C ; Lorenz, Elizabeth C. ; Cosio, Fernando G. / Enhanced posttransplant management of patients with diabetes improves patient outcomes. In: Kidney International. 2014 ; Vol. 86, No. 3. pp. 610-618.
@article{b69e6afde77c414f8387662ddc66e6d2,
title = "Enhanced posttransplant management of patients with diabetes improves patient outcomes",
abstract = "The survival of patients with diabetes mellitus in the general population has improved in recent years. Here we assessed whether similar trends have occurred in 1688 kidney recipients, including 413 with diabetes prior to transplant between 1996 and 2007. Compared to patients without diabetes, the 5-year mortality was significantly increased (hazard ratio (HR) 2.68 (1.95-3.69)) due to higher cardiovascular-, infection-, and malignancy-related deaths in those with diabetes. However, 5-year mortality in patients with diabetes significantly declined over time (HR 0.883 (0.817-0.954)), narrowing the mortality difference between patients with and those without diabetes and in more recent years largely eliminating it. Post transplant, patients with diabetes experienced a significant decline in major fatal/nonfatal cardiac events (HR 0.853 (0.782-0.930)) and infectious deaths over time. In contrast, neither cardiac events nor overall mortality declined in recipients without diabetes. The decline in mortality due to diabetes did not relate to a reduced pretransplant risk profile and was independent of posttransplant variables. The use of cardioprotective medications and glycemic control improved over time post transplant. Furthermore, graft function and serum albumin significantly improved over time and these parameters related to better survival (albumin, HR 0.365 (0.223-0.599); eGFR, HR 0.803 (0.756-0.852)). Thus, survival of kidney recipients with diabetes mellitus has improved markedly since 1996 likely reflecting, at least in part, enhanced posttransplant management and outcomes.",
keywords = "cardiovascular morbidity, cardiovascular mortality, diabetes mellitus, patient survival",
author = "Mira Keddis and {El Ters}, Mireille and Emilio Rodrigo and Patrick Dean and Mariana Wohlfahrtova and Kudva, {Yogish C} and Lorenz, {Elizabeth C.} and Cosio, {Fernando G}",
year = "2014",
doi = "10.1038/ki.2014.70",
language = "English (US)",
volume = "86",
pages = "610--618",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Enhanced posttransplant management of patients with diabetes improves patient outcomes

AU - Keddis, Mira

AU - El Ters, Mireille

AU - Rodrigo, Emilio

AU - Dean, Patrick

AU - Wohlfahrtova, Mariana

AU - Kudva, Yogish C

AU - Lorenz, Elizabeth C.

AU - Cosio, Fernando G

PY - 2014

Y1 - 2014

N2 - The survival of patients with diabetes mellitus in the general population has improved in recent years. Here we assessed whether similar trends have occurred in 1688 kidney recipients, including 413 with diabetes prior to transplant between 1996 and 2007. Compared to patients without diabetes, the 5-year mortality was significantly increased (hazard ratio (HR) 2.68 (1.95-3.69)) due to higher cardiovascular-, infection-, and malignancy-related deaths in those with diabetes. However, 5-year mortality in patients with diabetes significantly declined over time (HR 0.883 (0.817-0.954)), narrowing the mortality difference between patients with and those without diabetes and in more recent years largely eliminating it. Post transplant, patients with diabetes experienced a significant decline in major fatal/nonfatal cardiac events (HR 0.853 (0.782-0.930)) and infectious deaths over time. In contrast, neither cardiac events nor overall mortality declined in recipients without diabetes. The decline in mortality due to diabetes did not relate to a reduced pretransplant risk profile and was independent of posttransplant variables. The use of cardioprotective medications and glycemic control improved over time post transplant. Furthermore, graft function and serum albumin significantly improved over time and these parameters related to better survival (albumin, HR 0.365 (0.223-0.599); eGFR, HR 0.803 (0.756-0.852)). Thus, survival of kidney recipients with diabetes mellitus has improved markedly since 1996 likely reflecting, at least in part, enhanced posttransplant management and outcomes.

AB - The survival of patients with diabetes mellitus in the general population has improved in recent years. Here we assessed whether similar trends have occurred in 1688 kidney recipients, including 413 with diabetes prior to transplant between 1996 and 2007. Compared to patients without diabetes, the 5-year mortality was significantly increased (hazard ratio (HR) 2.68 (1.95-3.69)) due to higher cardiovascular-, infection-, and malignancy-related deaths in those with diabetes. However, 5-year mortality in patients with diabetes significantly declined over time (HR 0.883 (0.817-0.954)), narrowing the mortality difference between patients with and those without diabetes and in more recent years largely eliminating it. Post transplant, patients with diabetes experienced a significant decline in major fatal/nonfatal cardiac events (HR 0.853 (0.782-0.930)) and infectious deaths over time. In contrast, neither cardiac events nor overall mortality declined in recipients without diabetes. The decline in mortality due to diabetes did not relate to a reduced pretransplant risk profile and was independent of posttransplant variables. The use of cardioprotective medications and glycemic control improved over time post transplant. Furthermore, graft function and serum albumin significantly improved over time and these parameters related to better survival (albumin, HR 0.365 (0.223-0.599); eGFR, HR 0.803 (0.756-0.852)). Thus, survival of kidney recipients with diabetes mellitus has improved markedly since 1996 likely reflecting, at least in part, enhanced posttransplant management and outcomes.

KW - cardiovascular morbidity

KW - cardiovascular mortality

KW - diabetes mellitus

KW - patient survival

UR - http://www.scopus.com/inward/record.url?scp=84907597998&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907597998&partnerID=8YFLogxK

U2 - 10.1038/ki.2014.70

DO - 10.1038/ki.2014.70

M3 - Article

C2 - 24694990

AN - SCOPUS:84907597998

VL - 86

SP - 610

EP - 618

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 3

ER -